logo

For the Inventor, By the Inventor

St. Louis, MO, United States of America

Andrew E Gelman

This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Washington University, Quark Pharmaceuticals, Inc.. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew E Gelman. Retrieved from https://idiyas.com/inventor/andrew-e-gelman-d6p6hagq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Saint Louis, MO (US) (2015)
  • St. Louis, MO (US) (2017 - 2022)

Company Filing History:

goldMedal4 out of 1,383 
 
Washington University
 patents
silverMedal2 out of 67 
 
Quark Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2015-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 11351227 - Chemokine decoy receptors of rodent gammaherpesviruses and uses thereof (2022-06-07),
2. 11253510 - Anti-neutrophil activity on innate immune response (2022-02-22),
3. 9822362 - Compositions and methods for treating lung disease and injury (2017-11-21),
4. 9205100 - Compositions and methods for treating lung disease and injury (2015-12-08),

Title: Andrew E Gelman: Innovator in Immunology

Introduction

Andrew E Gelman is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of immunology, holding a total of 4 patents. His work focuses on developing innovative solutions that address critical health issues.

Latest Patents

Among his latest patents is the invention titled "Chemokine decoy receptors of rodent gammaherpesviruses and uses thereof." This patent provides compositions and methods related to immunology, specifically chemokine binding proteins and their applications. Another significant patent is "Anti-neutrophil activity on innate immune response," which discloses compositions, medical devices, and methods aimed at ameliorating sterile injury. This invention includes compositions featuring N-Acetylcysteine and an aminoquinoline, as well as medical devices with specific coatings.

Career Highlights

Andrew has worked with prestigious institutions, including Washington University and Quark Pharmaceuticals, Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

He has collaborated with notable colleagues, including Elena Feinstein and Svetlana Adamsky, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Andrew E Gelman is a distinguished inventor whose work in immunology has led to valuable patents and collaborations. His contributions continue to influence the field and improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…